Skip to main content
. 2022 Nov 12;11(22):3579. doi: 10.3390/cells11223579

Figure 2.

Figure 2

Inhibition of NLRP3 inflammasome-dependent pyroptosis alleviates liver fibrosis progression. (A) Experimental protocol of NLRP3 inhibitor MCC950 or saline application based on CCl4 injection in mice. (B) Representative liver histology of H&E and Sirius Red staining. The expression of α-SMA, NLRP3, GSDMD, and IL-1β was determined by immunohistochemistry. Black scale bar: 100 µm; Red scale bar: 50 µm. (CE) Serum levels of ALT, AST, and TP were measured. * p < 0.05.